NEW YORK (GenomeWeb News) — PerkinElmer’s bid to buy ViaCell has passed the Hart-Scott-Rodino antitrust waiting period, which expired yesterday.
 
Separately today, PerkinElmer declared a $.07 quarterly dividend payable on Feb. 8, 2008, to all stockholders of record at the end of Jan. 18, 2008.
 
The company is scheduled to release its quarterly earnings after the close of trading today.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.